Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
The influenza A virus [A/Chicken/Pennsylvania/1370/83 (H5N2)] that caused up to 80% mortality among chickens provided a model system for testing the efficacy of chemotherapeutic agents against highly virulent influenza virus. Amantadine and rimantadine administered in drinking water were efficacious both prophylactically and therapeutically. However, under conditions simulating natural transmission of virus, amantadine- and rimantadine-resistant viruses arose and were transmitted to other birds in contact with the infected chickens, causing mortality. Simultaneous administration of inactivated H5N2 vaccine and amantadine provided protection. Thus, chemotherapy may be useful in the treatment of a highly pathogenic influenza virus outbreak in humans or other animals when used in combination with vaccine.
D000218:Adamantane / Q000031:analogs & derivatives*; D000547:Amantadine / Q000627:therapeutic use*; D000818:Animals; D002645:Chickens; D004352:Drug Resistance, Microbial; D009980:Influenza A virus / Q000276:immunology*; D005585:Influenza in Birds / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D012299:Rimantadine / Q000627:therapeutic use*; D014611:Vaccination; D014765:Viral Vaccines / Q000276:immunology
D014765:Viral Vaccines; D012299:Rimantadine; D000547:Amantadine; D000218:Adamantane